Linda Palczuk - 17 Dec 2024 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role
Director
Signature
/s/ Jerad G. Seurer, as attorney-in-fact
Issuer symbol
AVDL
Transactions as of
17 Dec 2024
Net transactions value
$0
Form type
4
Filing time
19 Dec 2024, 16:20:43 UTC
Previous filing
10 Dec 2024
Next filing
27 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVDL Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 17 Dec 2024 Ordinary Shares 25,000 $10.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options become exercisable in three equal annual installments on each of the first three anniversaries following the 12/17/2024 grant date, subject to the Reporting Person's continued service at each such vesting date.